A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of this study is to test whether the combination of fianlimab, cemiplimab, and ipilimumab is a safe and effective treatment that causes few or mild side effects for locally advanced or metastatic, unresectable, refractory melanoma.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek co najmniej 18 lat
- •Potwierdzona diagnoza zaawansowanego czerniaку skóry lub błon śluzowych, który się rozprzestrzenia lub nie da się całkowicie usunąć operacyjnie
- •Czerniak musi być oporny na wcześniejsze leczenie lekami immunoterapeutycznymi (PD-1 lub PD-1 + LAG-3)
- •Posiadanie mierzalnych zmian nowotworowych
- •Dobre ogólne samopoczucie (stopień wydolności 0-1)
- •Odpowiednie wyniki badań laboratoryjnych
- •Zdolność do wyrażenia świadomej zgody na udział w badaniu
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- October 7, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (12)
Cedars-Sinai Medical Center
Los Angeles, United States
Stanford University (Data Collection Only)
Stanford, United States
Hartford Healthcare Alliance (Data Collection Only)
Hartford, United States
Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
Basking Ridge, United States
Hackensack Meridian Health (Data Collection Only)
Hackensack, United States
Memorial Sloan Kettering Monmouth (All Protocol Activities)
Middletown, United States
Memorial Sloan Kettering Bergen (Limited Protocol Activities)
Montvale, United States
Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities)
Commack, United States
Memorial Sloan Kettering Westchester (All Protocol Activities)
Harrison, United States
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, United States
Memorial Sloan Kettering Nassau (Limited Protocol Activities)
Uniondale, United States
MD Anderson Cancer Center (Data Collection Only)
Houston, United States
Trial contact
James Smithy, MD
Michael Postow, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 10/8/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.